Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.85 – $1.85
0% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $669.5M | $793.5M | $648.7M | $778.6M | $840.8M | $950.7M | $1.04B | $996.4M |
| Cost of revenue | $199.5M | $229.1M | $212.7M | $286.9M | $339.1M | $418.6M | $457.0M | $442.1M |
| Gross profit | $470.0M | $564.4M | $436.0M | $491.8M | $501.8M | $532.1M | $574.1M | $554.3M |
| Gross margin | 70.2% | 71.1% | 67.2% | 63.2% | 59.7% | 56.0% | 55.5% | 55.6% |
| R&D | $104.8M | $151.5M | $192.6M | $297.8M | $431.0M | $380.9M | $216.5M | $135.7M |
| Operating income | $52.1M | $21.8M | −$167.1M | −$293.6M | −$506.6M | −$516.2M | −$126.0M | −$52.9M |
| EBITDA | $95.1M | $83.0M | −$106.9M | −$201.1M | −$430.3M | −$382.5M | $60.2M | $88.8M |
| Net income | $23.9M | $29.0M | −$191.3M | −$276.5M | −$436.5M | −$477.6M | −$214.9M | $48.6M |
| Net margin | 3.6% | 3.7% | -29.5% | -35.5% | -51.9% | -50.2% | -20.8% | 4.9% |
| EPS (diluted) | 0.02 | 0.02 | -0.11 | -0.16 | -0.25 | -0.27 | -0.12 | 0.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.2B | $0.05 | $0.04–$0.05 | 1 |
| 2027 | $1.4B | $0.05 | $0.04–$0.06 | 1 |
| 2028 | $1.6B | $0.09 | $0.08–$0.11 | 1 |
Forward consensus · source: Financial Modeling Prep
MICROPORT SCIENTIFIC CORP
No one on the platform currently holds MCRPF.
No tracked institution reports a position in MCRPF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2021-06-29 | 1.000778196-for-1 |
| 2020-06-23 | 1.0024055918663761-for-1 |
| 2019-06-18 | 1.0057457600253605-for-1 |
| 2018-05-17 | 1.0023764258555132-for-1 |
No one on the platform has traded MCRPF yet.
| +0.00% |
| $3.0B |
| — |
| JXFGFJinxin Fertility Group Limited | $0.29 | +0.00% | $743M | — |
| MCVEFMedicover AB (publ) | $27.25 | +0.00% | $4.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.9× sales vs its 3.9× historical median P/S.
Fair value ≈ $3.83 · price $0.85 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.